Latest "GCS Ltd" News Stories

07:29 EDT 23rd May 2018 | BioPortfolio

Here are the most relevant search results for "GCS Ltd" found in our extensive news archives from over 250 global news sources.

More Information about GCS Ltd on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about GCS Ltd for you to read. Along with our medical data and news we also list GCS Ltd Clinical Trials, which are updated daily. BioPortfolio also has a large database of GCS Ltd Companies for you to search.

Showing News Articles 1–25 of 430,000+

Wednesday 23rd May 2018

[Comment] Take a blood pressure pill or undergo renal denervation?

Renal denervation could be a new treatment approach for patients with treatment-resistant hypertension. The findings of the SYMPLICITY HTN-2 trial1 suggested that renal denervation was associated with a major reduction in systolic blood pressure based on office measurements of blood pressure. However, ambulatory blood pressure is the state-of-the-art technique for measuring blood pressure in patie...

Problem gambling: five minutes with . . . Henrietta Bowden-Jones

“Pathological gambling is a serious public health problem, affecting nearly 1% of people in the UK. Around half a million people are pathological gamblers but an estimated two million are at risk of...

RCGP calls for national campaign to tackle loneliness

Loneliness is a public health epidemic, and a national campaign is needed to raise awareness of the issue, the Royal College of General Practitioners (RCGP) has said.The college has published an...

UK government vows to adopt stringent WHO clean air targets

The UK government has published a draft plan for its upcoming clean air strategy, which includes a target to reduce particulate matter emissions by 46% by 2030.The draft strategy,1 published for...

Watson-Marlow Limited is Honoured with Queen’s Award for Enterprise

The award recognises the Company’s development of its Qdos pump technology the world’s first self-contained, chemical metering pump. Qdos, the innovative chemical metering pump wins the Queen's Award for Enterprise: Innovation 2018. This category rewards world class innovation coupled with proof of five years of sustained sales...

Survey Reveals More Than 1 in 3 Healthcare Organizations Have Suffered a Cyberattack While 1 in 10 Have Paid a Ransom

Imperva, Inc. (NASDAQ:IMPV), a leading global provider of best-in-class cybersecurity solutions on-premises, in the cloud and across hybrid environments, today announced the results of a survey showing more than one in three healthcare organizations have suffered a cyberattack within the last year, while almost one in 10 have paid a ransom or extortion ...

Just Released Data Registers Mobility Trends of Certified PAs

NCCPA Documents Growth in Rural Areas and Surgical Specialties For the fifth straight year, the National Commission on Certification of Physician Assistants (NCCPA), has published PA workforce data — the most comprehensive statistical report on PAs nationwide, with over 91% of certified PAs providing input.

Wenzel Spine Announces Publication of Case Series Detailing Endoscopic Transforaminal Decompression and Fusion Technique with VariLift-LX

24 Consecutive Patient Case Study of New Endoscopic Surgical Technique with Stand-Alone Use of the VariLift-LX Expandable Stand-Alone Interbody Fusion System Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders, today announced a 24 Consecutive Patient Case Series detai...

LogicBio Therapeutics Appoints Dean Falb, Ph.D., as Chief Scientific Officer

Genome editing company adds drug development expert in pursuit of breakthrough medicines for pediatric patients LogicBio Therapeutics, Inc., a genetic medicine company founded to develop safe and lasting treatments for children with life-threatening early onset diseases, today announced the a

Navigant, Lumere Collaborate to Help Healthcare Providers Target Clinical and Financial Variation

Combination of analytics, research, and performance improvement expertise to support evidence-based medical device and drug selection, utilization Navigant (NYSE: NCI) and Lumere today announced a collaboration to help healthcare providers implement evidence-based, technology-enabled consulting solutions aimed at reducing clinical and financial variati...

Analytics 4 Life® Expands Its Medical Advisory Board with Global Experts in Cardiology

Experience and global insights to guide Company’s clinical program expansion to China Analytics 4 Life, a digital health company applying the power of artificial intelligence to develop solutions that improve existing care pathways, today announced that it has expanded its Medical Advisory Board with the addition of two global experts in c

Community Health Systems Announces Early Tender Results for Exchange Offers and Extends Early Tender Deadline

Community Health Systems, Inc. (the “Company”) (NYSE:CYH) today announced that its wholly owned subsidiary, CHS/Community Health Systems, Inc. (the “Issuer”), has amended certain terms of its previously commenced offers to exchange (each, an “Exchange Offer” and, collectively, the “Exchange Offers”) (i) up to $1,925 million aggregate princi...

LHC Group’s First-Quarter CMS Star Ratings Continue to Outperform National Averages

Industry analysts note that company’s performance “continues to shine” LHC Group, Inc.’s (NASDAQ: LHCG) quality and patient satisfaction ratings once again outperformed national averages and industry peers – according to the latest Centers for Medicare and Medicaid Services (CMS) Five-Star Quality Rating System results released in April 2018....

Anthem, Inc. to Acquire Aspire Health

Anthem, Inc. (NYSE:ANTM) today announced that the company has entered into an agreement to acquire Aspire Health, the nation’s largest non-hospice, community-based palliative care provider. “Anthem is focused on enhancing our ability to offer innovative, integrated clinical care models that can improve the quality of healthcare and deliver bet...

Patterson Companies Announces Leadership Team Additions

Donald J. Zurbay Named Chief Financial Officer Andrea Frohning Named Chief Human Resources Officer Patterson Companies (Nasdaq: PDCO) today announced additions to further enhance the Company’s leadership team. Patterson has appointed Donald J. Zurbay as Chief Financial Officer, effective June 29, 2018. Patterson also announced that Andrea Fr...

FDA clears Amgen’s Prolia for glucocorticoid osteoporosis

US regulators have approved a new indication for Amgen’s Prolia, allowing its use to treat glucocorticoid-induced osteoporosis (GIOP) in men and women at high risk of fracture.

Clinigen, Mitsubishi link for early access programme

Clinigen says it has partnered with Mitsubishi Tanabe Pharma to initiate a Managed Access Program in Europe for edaravone, an intravenous treatment for amyotrophic lateral sclerosis (ALS).

UK streams £30m into global fight against AMR

The UK government has announced that it will stream £30 million into global efforts to fight antimicrobial resistance (AMR).

Merck’s KEYTRUDA® (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment for Squamous Non-Small Cell Lung Cancer (NSCLC) in Pivotal Phase 3 KEYNOTE-407 Trial

KEYTRUDA Has Now Demonstrated an Improved Survival Benefit in Advanced NSCLC in Five Phase 3 Trials Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the pivotal Phase 3 KEYNOTE-407 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with carboplatin-paclitaxel or nab-paclitaxel, as first-l...

Agency round up news

Executive Insight launches new website, precisioneffect acquires new agency and AMICULUM opens new office

Sage Therapeutics to Present at Bernstein’s 34th Annual Strategic Decisions Conference

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the Company will present at Bernstein’s 34th Annual Strategic Decisions Conference on Wednesday, May 30, 2018 at 11:00 A.M. ET in New York, NY. A live webcast...

First Edition: May 23, 2018

Today's early morning highlights from the major news organizations.

Ferring invests $15m in Israeli unit Bio-Technology General

New technologies and production lines at BTG Israel plant will support the development of new treatments in reproductive medicine and women’s health.

Foundry3 targets tailored patient support programmes

Agency partners with ERT to improve health outcomes

Metastatic Renal Cell Carcinoma mRCC Pipeline Insight, 2018 [Report Updated: 14022018] Prices from USD $1250

"Metastatic Renal Cell Carcinoma mRCC Pipeline Insight, 2018 report by DelveInsight offers comprehensive Insight of the pipeline under development therapeutics scenario and growth prospects across Metastatic Renal Cell Carcinoma mRCC development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pip...

Quick Search


News Quicklinks